Rapid reperfusion of the infarct-related artery is the cornerstone of therapy for the
management of acute ST-elevation myocardial infarction (STEMI). Canada's geography …

BACKGROUND: ST-segment–elevation myocardial infarction (STEMI) guidelines
recommend pharmaco-invasive treatment if timely primary percutaneous coronary …

Background: Recent clinical trial data support a pharmacoinvasive strategy as an alternative
to primary percutaneous coronary intervention (pPCI) in ST-segment elevation myocardial …

Abstract Background The recently released Canadian cardiac care quality indicators include
30-day in-hospital mortality and readmission rates after percutaneous coronary intervention …

Background A low proportion of patients with ST-elevation myocardial infarction (STEMI) in
low-to middle-income countries receive reperfusion therapy. Although primary percutaneous …

Objective The primary percutaneous coronary intervention (PPCI) is the preferred
reperfusion strategy for ST-segment elevation myocardial infarction (STEMI). The …

Aims Pharmaco-invasive percutaneous coronary intervention (PI-PCI) is recommended for
patients with ST-elevation myocardial infarction (STEMI) who are unable to undergo timely …

BACKGROUND: In patients with ST-segment–elevation myocardial infarction complicated
by cardiogenic shock, primary percutaneous coronary intervention (pPCI) is the preferred …

Background Little is known about Emergency Medical Services (EMS) use and pre-hospital
triage of patients with acute ST-elevation myocardial infarction (STEMI) in Arabian Gulf …

The novel coronavirus pandemic has led to morbidity and mortality throughout the world.
Until now, it is a highly virulent contagion attacking the respiratory system in humans …